EQUITY | EQUITY The following tables provide a summary of the changes in total equity, equity attributable to controlling interest, and equity attributable to noncontrolling interests for each of the periods indicated: Common Shares and Capital in Retained Treasury Accumulated Other Total Equity - Noncontrolling Total Balance at September 30, 2020 $ 482.5 $ 1,235.6 $ (921.8) $ (99.1) $ 697.2 $ 5.7 $ 702.9 Net income (loss) — 24.4 — — 24.4 0.8 25.2 Other comprehensive income (loss) — — — 15.6 15.6 — 15.6 Share-based compensation 8.2 — — — 8.2 — 8.2 Dividends declared ($0.62 per share) — (35.7) — — (35.7) — (35.7) Treasury share purchases — — (38.4) — (38.4) — (38.4) Treasury share issuances (0.1) — 1.3 — 1.2 — 1.2 Balance at January 2, 2021 $ 490.5 $ 1,224.4 $ (958.8) $ (83.5) $ 672.6 $ 6.4 $ 679.0 Net income (loss) — 310.0 — — 310.0 0.2 310.2 Other comprehensive income (loss) — — — 5.5 5.5 — 5.5 Share-based compensation 17.7 — — — 17.7 — 17.7 Dividends declared ($0.62 per share) — (34.2) — — (34.2) — (34.2) Treasury share purchases — — (23.8) — (23.8) — (23.8) Treasury share issuances (21.7) — 28.3 — 6.6 — 6.6 Acquisition of noncontrolling interests (13.4) — — — (13.4) (6.7) (20.1) Balance at April 3, 2021 $ 473.0 $ 1,500.2 $ (954.3) $ (78.0) $ 940.9 $ — $ 940.9 Net income (loss) — 225.9 — — 225.9 — 225.9 Other comprehensive income (loss) — — — 4.1 4.1 — 4.1 Share-based compensation 8.1 — — — 8.1 — 8.1 Dividends declared ( $0.62 per share) — (35.1) — — (35.1) — (35.1) Treasury share purchases — — (28.8) — (28.8) — (28.8) Treasury share issuances (9.7) — 17.0 — 7.3 — 7.3 Balance at July 3, 2021 $ 471.4 $ 1,691.0 $ (966.1) $ (73.9) $ 1,122.4 $ — $ 1,122.4 The sum of the components may not equal due to rounding. Common Shares and Capital in Retained Treasury Accumulated Other Total Equity - Noncontrolling Total Balance at September 30, 2019 $ 442.2 $ 1,274.7 $ (904.3) $ (93.9) $ 718.7 $ 4.5 $ 723.2 Net income (loss) — (71.4) — — (71.4) 0.1 (71.3) Other comprehensive income (loss) — — — 2.9 2.9 — 2.9 Share-based compensation 7.0 — — — 7.0 — 7.0 Dividends declared ($0.58 per share) — (33.5) — — (33.5) — (33.5) Treasury share issuances (0.3) — 1.2 — 0.9 — 0.9 Balance at December 28, 2019 $ 448.9 $ 1,169.8 $ (903.1) $ (91.0) $ 624.6 $ 4.7 $ 629.3 Net income (loss) — 252.2 — — 252.2 0.2 252.4 Other comprehensive income (loss) — — — (16.9) (16.9) — (16.9) Share-based compensation 12.0 — — — 12.0 — 12.0 Dividends declared ($0.58 per share) — (33.0) — — (33.0) — (33.0) Treasury share purchases — — (52.9) — (52.9) — (52.9) Treasury share issuances (10.5) — 14.2 — 3.7 — 3.7 Balance at March 28, 2020 $ 450.5 $ 1,389.0 $ (941.9) $ (107.9) $ 789.7 $ 4.9 $ 794.6 Net income (loss) — 202.8 — — 202.8 0.5 203.3 Other comprehensive income (loss) — — — 5.7 5.7 — 5.7 Share-based compensation 22.8 — — — 22.8 — 22.8 Dividends declared ($0.58 per share) — (34.9) — — (34.9) — (34.9) Treasury share purchases — — (0.2) — (0.2) — (0.2) Treasury share issuances (7.5) — 20.0 — 12.5 — 12.5 Balance at June 27, 2020 $ 465.8 $ 1,557.0 $ (922.1) $ (102.2) $ 998.5 $ 5.4 $ 1,003.9 The sum of the components may not equal due to rounding. Changes in AOCL by component were as follows for each of the periods indicated: Three Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) in Accumulated Other Balance at April 3, 2021 $ 1.9 $ (1.3) $ (78.6) $ (78.0) Other comprehensive income (loss) before reclassifications 2.4 2.2 — 4.6 Amounts reclassified from accumulated other comprehensive net income (loss) — 0.7 (0.5) 0.2 Income tax benefit (expense) — (0.8) 0.1 (0.7) Net current period other comprehensive income (loss) 2.4 2.1 (0.4) 4.1 Balance at July 3, 2021 $ 4.3 $ 0.8 $ (79.0) $ (73.9) Balance at March 28, 2020 $ (22.7) $ (17.9) $ (67.3) $ (107.9) Other comprehensive income (loss) before reclassifications 5.3 (4.0) — 1.3 Amounts reclassified from accumulated other comprehensive net income (loss) — 4.2 0.4 4.6 Income tax benefit (expense) — (0.1) (0.1) (0.2) Net current period other comprehensive income (loss) 5.3 0.1 0.3 5.7 Balance at June 27, 2020 $ (17.4) $ (17.8) $ (67.0) $ (102.2) The sum of the components may not equal due to rounding. Nine Months Ended Foreign Currency Net Unrealized Gain (Loss) Net Unrealized Gain (Loss) in Accumulated Other Balance at September 30, 2020 $ (6.2) $ (15.1) $ (77.8) $ (99.1) Other comprehensive income (loss) before reclassifications 10.5 15.5 — 26.0 Amounts reclassified from accumulated other comprehensive net income (loss) — 5.9 (1.6) 4.3 Income tax benefit (expense) — (5.5) 0.4 (5.1) Net current period other comprehensive income (loss) 10.5 15.9 (1.2) 25.2 Balance at July 3, 2021 $ 4.3 $ 0.8 $ (79.0) $ (73.9) Balance at September 30, 2019 $ (17.4) $ (8.1) $ (68.4) $ (93.9) Other comprehensive income (loss) before reclassifications — (20.9) — (20.9) Amounts reclassified from accumulated other comprehensive net income (loss) — 7.8 1.9 9.7 Income tax benefit (expense) — 3.4 (0.5) 2.9 Net current period other comprehensive income (loss) — (9.7) 1.4 (8.3) Balance at June 27, 2020 $ (17.4) $ (17.8) $ (67.0) $ (102.2) The sum of the components may not equal due to rounding. Dividends On July 27, 2020, the Scotts Miracle-Gro Board of Directors approved an increase in the Company’s quarterly cash dividend from $0.58 to $0.62 per Common Share. In addition, on July 27, 2020, the Scotts Miracle-Gro Board of Directors approved a special cash dividend of $5.00 per Common Share, which was paid on September 10, 2020 to all shareholders of record at the close of business on August 27, 2020. On July 30, 2021, the Scotts Miracle-Gro Board of Directors approved an increase in the Company’s quarterly cash dividend from $0.62 to $0.66 per Common Share, which will be first paid in the fourth quarter of fiscal 2021. Share Repurchases On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the share repurchase authorization through March 28, 2020. The amended authorization allowed for repurchases of Common Shares of up to an aggregate amount of $1,000.0 through March 28, 2020. During fiscal 2020 through March 28, 2020, Scotts Miracle-Gro repurchased 0.4 million Common Shares under this share repurchase authorization for $48.2. From the effective date of this share repurchase authorization in the fourth quarter of fiscal 2014 through March 28, 2020, Scotts Miracle-Gro repurchased approximately 8.7 million Common Shares for $762.8. On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. The authorization provides the Company with flexibility to purchase Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization may be suspended or discontinued by the Board of Directors at any time, and there can be no guarantee as to the timin g or amount of any repurchases. There were no share repurchases under this share repurchase authorization during fiscal 2020. During the three and nine months ended July 3, 2021, Scotts Miracle-Gro repurchased approximately 0.1 million and 0.4 million Common Shares under this share repurchase authorization for $25.0 and $75.6, respectively. The “Treasury share purchases” lines in the tables above include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $3.8 and $15.5 for the three and nine months ended July 3, 2021, respectively, and $0.2 and $4.9 for the three and nine months ended June 27, 2020, respectively. Share-Based Awards The following is a summary of the share-based awards granted during each of the periods indicated: Nine Months Ended July 3, June 27, Employees Options 183,553 — Restricted stock units 69,758 118,410 Performance units 1,903 37,570 Non-Employee Directors Restricted and deferred stock units 8,518 16,295 Total share-based awards 263,732 172,275 Aggregate fair value at grant dates $ 29.9 $ 20.9 Total share-based compensation was as follows for each of the periods indicated: Three Months Ended Nine Months Ended July 3, June 27, July 3, June 27, Share-based compensation $ 8.1 $ 22.8 $ 34.0 $ 41.8 Related tax benefit recognized 2.1 5.8 6.0 9.7 Stock Options Stock option activity during the nine months ended July 3, 2021 was as follows: No. of Wtd. Avg. Awards outstanding at September 30, 2020 619,225 $ 57.90 Granted 183,553 236.53 Exercised (234,587) 51.18 Awards outstanding at July 3, 2021 568,191 118.38 Exercisable 384,638 62.00 |